Ye‐Hui Chen
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Cancer-related molecular mechanisms research
Papers in
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 4
-
- Cancer-related molecular mechanisms research 3
- Co-authors
- Ning Xu (24 shared papers)Xue‐Yi Xue (22 shared papers)Yong Wei (20 shared papers)Shao‐Hao Chen (18 shared papers)Qing‐Shui Zheng (21 shared papers)Zhi‐Bin Ke (17 shared papers)Yu‐Peng Wu (10 shared papers)Tingting Lin (10 shared papers)
In The Last Decade
Ye‐Hui Chen
23 papers receiving 301 citations
Peers
Comparison fields: 5 of 34
- Pulmonary and Respiratory Medicine 130
- Cancer Research 45
- Urology 10
- Oncology 30
- Molecular Biology 53
Countries citing papers authored by Ye‐Hui Chen
This map shows the geographic impact of Ye‐Hui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye‐Hui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye‐Hui Chen more than expected).
Fields of papers citing papers by Ye‐Hui Chen
This network shows the impact of papers produced by Ye‐Hui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye‐Hui Chen. The network helps show where Ye‐Hui Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye‐Hui Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 36 | |
| 2 | 2020 | 35 | |
| 3 | 2020 | 32 | |
| 4 | 2017 | 25 | |
| 5 | 2021 | 23 | |
| 6 | 2021 | 21 | |
| 7 | 2020 | 18 | |
| 8 | 2020 | 15 | |
| 9 | 2019 | 14 | |
| 10 | 2020 | 11 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2020 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2023 | 5 | |
| 19 | 2024 | 3 | |
| 20 | 2021 | 2 |
About Ye‐Hui Chen
Ye‐Hui Chen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Urology, Surgery and Oncology, having authored 24 papers that have together received 303 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Renal cell carcinoma treatment (4 papers), Cancer-related molecular mechanisms research (3 papers), Adrenal and Paraganglionic Tumors (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Testicular diseases and treatments (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (130 citations), Cancer Research (45 citations), Urology (10 citations), Oncology (30 citations) and Molecular Biology (53 citations). Ye‐Hui Chen has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Ning Xu, Xue‐Yi Xue, Yong Wei, Shao‐Hao Chen, Qing‐Shui Zheng, Zhi‐Bin Ke, Yu‐Peng Wu, Tingting Lin, Yun‐Zhi Lin and Junming Zhu. Their work appears in journals such as Frontiers in Oncology, Aging, Journal of Cancer, Journal of Cellular and Molecular Medicine and Combinatorial Chemistry & High Throughput Screening.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.